R&D cost to be reflected in insurance drug prices.

Published: 2000-04-05 14:03:00

Updated: 2000-04-05 14:03:00

For the international competitiveness in the pharmaceutical industry to be enhanced and its leading role in the national economy of 21th century to be fostered, the KPMA raised several issues during an interview with President Kim on March 30 that the new drug R&D cost should be provisionally acc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK